‘Now Approved’ Message
Back to: Cablivi “Now Approved” Web Page
Brand: Cablivi (caplacizumab-yhdp), Injection
Parent Company: Sanofi Genzyme
Drug Type: Prescription
Drug Category: Hematology
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.cablivi.com/
HCP Website:
Parent Company: Sanofi Genzyme
Drug Type: Prescription
Drug Category: Hematology
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.cablivi.com/
HCP Website: